1. A retrospective case-control study to assess the impact of enhanced supportive care for patients with advanced lung cancer. (January 2019) Authors: Vijeratnam, N.; Stockley, A.; Godfrey, N.; Jenkins, E.; Dorey, N.; Toy, E. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK. Issue 1 (January 2022) Authors: Banfill, K.; Croxford, W.; Fornacon-Wood, I.; Wicks, K.; Ahmad, S.; Britten, A.; Carson, C.; Dorey, N.; Hatton, M.; Hiley, C.; Thippu Jayaprakash, K.; Jegannathen, A.; Koh, P.; Panakis, N.; Peedell, C.; Pope, A.; Powell, C.; Stilwell, C.; Thomas, B.; Toy, E. Journal: Clinical oncology Issue: Volume 34:Issue 1(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. Issue 3 (March 2018) Authors: Sanganalmath, P.; Lester, J.E.; Bradshaw, A.G.; Das, T.; Esler, C.; Roy, A.E.F.; Toy, E.; Lester, J.F.; Button, M.; Wilson, P.; Comins, C.; Atherton, P.; Pickles, R.; Foweraker, K.; Walker, G.A.; Keni, M.; Hatton, M.Q. Journal: Clinical oncology Issue: Volume 30:Issue 3(2018) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and tolerability of tyrosine kinase inhibitors as treatment for advanced non-small cell carcinoma (NSCLC) in the elderly: a real-world practice three-centre experience. (January 2019) Authors: Silva, N.; Goranov, B.; Parslow, D.; Chambers, J.; Talbot, T.; Dorey, N.; Toy, E. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-world outcomes with pembrolizumab in patients with treatment-naive advanced/metastatic NSCLC in the UK: multicentre retrospective observational study. (January 2019) Authors: Tokaca, N.; Gomes, F.; Lau, S.; Jackson, A.; Gradwell, M.; Gyi, M.; Reinius, M.; Valentine, E.; Winn, E.; Bhosle, J.; O'Brien, M.; Yousaf, N.; Blackhall, F.; Gilligan, D.; Treece, S.; Yip, K.; Geldart, T.; Baluch, S.; Gulliford, T.; Muthuramalingam, S. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic. Issue 8 (August 2020) Authors: Faivre-Finn, C.; Fenwick, J.D.; Franks, K.N.; Harrow, S.; Hatton, M.Q.F.; Hiley, C.; McAleese, J.J.; McDonald, F.; O'Hare, J.; Peedell, C.; Pope, T.; Powell, C.; Rulach, R.; Toy, E. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗